Trade TEVA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Teva Pharmaceutical Industries Limited (TEVA) is trading at US$38.98, down 0.54% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$43.51B. Over the past 52 weeks, TEVA has traded between US$18.21 and US$39.70. On Syfe you can trade TEVA with $0 commission and add it to your watchlist.
| Previous close | US$39.19 |
|---|---|
| Market cap | US$43.51B |
| P/E ratio | 14.09 |
| 52-week range | US$18.21 – US$39.70 |
| Volume | 5.47M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
Year: 1982
Teva Pharmaceutical Industries Limited (TEVA) stock is trading at US$38.98, -0.54% from the previous close of US$39.19.
The market cap for Teva Pharmaceutical Industries Limited (TEVA) stock is approximately US$43.51B.
The price-to-earnings ratio for Teva Pharmaceutical Industries Limited (TEVA) is 14.09, based on the latest reported earnings.
The 52-week high for Teva Pharmaceutical Industries Limited (TEVA) stock is US$39.70.
The 52-week low for Teva Pharmaceutical Industries Limited (TEVA) stock is US$18.21.
Teva Pharmaceutical Industries Limited (TEVA) does not currently pay a dividend.
Stay on top of TEVA
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
